Which nerve block eases kidney transplant pain better?
NCT ID NCT07059455
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared two types of nerve blocks — erector spinae plane block and transmuscular quadratus lumborum block — for pain after kidney transplant. Forty adults received one of the two blocks with bupivacaine. Researchers measured pain scores and painkiller use over 24 hours to see which block worked better.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bupivacaine (Marcaine)
- What this could lead to
- If one block works better, it could improve pain control after kidney transplant and reduce reliance on systemic painkillers.
- What could go wrong
- This is a small, completed study with only 40 patients. Results may not apply to all transplant patients, and nerve blocks carry risks like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Mar 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Renal transplantation * Patients between the ages of 18-65 Exclusion Criteria: * Patients who do not agree to participate in the study, * Patients havecoagulopathy, liver function problems, local anesthetic allergy * Body mass index (BMI) \> 40
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for End-stage renal disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kartal Dr Lutfi Kirdar City Hospital
Istanbul, Kartal, 34000, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a deep breath and a hint of lemongrass take the sting out of dialysis needles?
- New fluid aims to keep donated kidneys healthier
- Can better training get doctors to talk about what matters most to dying veterans?
- Can pedaling during dialysis make red blood cells more flexible?
- 30,000 dialysis patients tracked to map what works
- Donated artery grafts tested as lifeline for dialysis patients